Quick Answer
AVANOS MEDICAL, INC. reported Revenue (ASC 606) of $701.20 million for fiscal year 2025.
AVANOS MEDICAL, INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $701.20M | +1.9% |
| 2024 | $687.80M | +2.2% |
| 2023 | $673.30M | -1.6% |
| 2022 | $684.10M | +16.5% |
| 2021 | $587.00M | -17.9% |
| 2020 | $714.80M | +2.5% |
| 2019 | $697.60M | +6.9% |
| 2018 | $652.30M | +6.7% |
| 2017 | $611.60M | +8.0% |
| 2016 | $566.20M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $177.80M | +4.3% | +1.6% |
| June 30, 2025 | $175.00M | +1.9% | +4.5% |
| March 31, 2025 | $167.50M | +0.8% | -1.7% |
| September 30, 2024 | $170.40M | -0.5% | -0.8% |
| June 30, 2024 | $171.70M | +1.4% | +3.4% |
| March 31, 2024 | $166.10M | +4.3% | -3.0% |
| September 30, 2023 | $171.30M | -0.6% | +1.1% |
| June 30, 2023 | $169.40M | -0.9% | +6.3% |
- AVANOS MEDICAL, INC. showed an increase of +1.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, AVANOS MEDICAL, INC.’s revenue (asc 606) has grown by 23.8% (from $566.20 million to $701.20 million).
- The most recent figure is from AVANOS MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: